Multidimensional Protein Solubility Optimization with an Ultrahigh-Throughput Microfluidic Platform

Area of Science:

• Biochemistry
• Biotechnology
• Pharmaceutical Sciences

Background:

• Protein-based biologics offer low toxicity and high target specificity, making them ideal for drug development.
• Elevated concentrations are often required for therapeutic applications, but insufficient protein solubility presents a significant challenge.
• Current methods for protein solubility screening are time-consuming and require substantial protein amounts.

Purpose of the Study:

• To develop an ultrahigh-throughput microfluidic platform for rapid protein solubility screening.
• To enable quantitative comparison of formulation excipients and their combinatorial effects on protein solubility.
• To facilitate the screening of large protein libraries, including the impact of mutations and pH on solubility.

Main Methods:

• An ultrahigh-throughput microfluidic platform was designed for protein solubility screening.
• The platform integrates sample preparation, incubation, and measurement within minutes.
• The system requires minimal protein input (20 microg) and generates a high volume of data points (10,000).

Main Results:

• The microfluidic platform demonstrated a >10-fold improvement in protein reduction and a 1000-fold increase in data points compared to previous methods.
• Quantitative comparisons of various formulation excipients (e.g., sodium chloride, polysorbate, histidine, arginine, sucrose) were performed.
• The study successfully assessed the combinatorial effects of multiple additives, optimal pH, and the impact of mutations on protein solubility.

Conclusions:

• The developed microfluidic platform significantly accelerates protein solubility screening.
• This approach reduces material and time costs, enabling comprehensive multidimensional solubility optimization.
• The platform streamlines biotherapeutic drug development and enhances understanding of protein solubility and excipient interactions.